Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Discovery of tumor immune infiltration-related snoRNAs for predicting tumor immune microenvironment status and prognosis in lung adenocarcinoma. Local targets link to admitted publications; unresolved targets remain external evidence.
The long non-coding RNA SNHG5 regulates gefitinib resistance in lung adenocarcinoma cells by targetting miR-377/CASP1 axis
2018 · External reference
10.1016/j.jgg.2015.07.001
10.1016/j.jgg.2015.07.001 · External reference
10.3322/caac.21338
10.3322/caac.21338 · External reference
10.1002/cam4.2583
10.1002/cam4.2583 · External reference
Prognosis of lung adenocarcinoma patients with NTRK3 mutations to immune checkpoint inhibitors
10.3389/fphar.2020.01213 · 2020 · External reference
10.1002/cam4.2580
10.1002/cam4.2580 · External reference
Immune landscape of colorectal cancer tumor microenvironment from different primary tumor location
10.3389/fimmu.2018.01578 · 2018 · External reference
10.1038/s41586-019-1032-7
10.1038/s41586-019-1032-7 · External reference
10.1016/j.cell.2017.04.014
10.1016/j.cell.2017.04.014 · External reference
Identification and validation of an immune cell infiltrating score predicting survival in patients with lung adenocarcinoma
10.1186/s12967-019-1964-6 · 2019 · External reference
Clinical significance of SNORA42 as an oncogene and a prognostic biomarker in colorectal cancer
10.1136/gutjnl-2015-309359 · 2017 · External reference
snoRNA and piRNA expression levels modified by tobacco use in women with lung adenocarcinoma
10.1371/journal.pone.0183410 · 2017 · External reference
The small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosis
10.1038/sj.bjc.6606076 · 2011 · External reference
Small nucleolar RNA signatures as biomarkers for non-small-cell lung cancer
10.1186/1476-4598-9-198 · 2010 · External reference
Serum long non-coding RNA, snoRNA host gene 5 level as a new tumor marker of malignant melanoma
10.1111/exd.12868 · 2016 · External reference
Long non-coding RNA SNHG5 suppresses gastric cancer progression by trapping MTA2 in the cytosol
10.1038/onc.2016.110 · 2016 · External reference
10.1038/onc.2011.449
10.1038/onc.2011.449 · External reference
10.1038/s41388-018-0420-z
10.1038/s41388-018-0420-z · External reference
10.1111/j.1365-2567.2007.02587.x
10.1111/j.1365-2567.2007.02587.x · External reference
A prognostic Nomogram combining immune-related gene signature and clinical factors predicts survival in patients with lung adenocarcinoma
10.3389/fonc.2020.01300 · 2020 · External reference
10.1093/bioinformatics/btm254
10.1093/bioinformatics/btm254 · External reference
10.1093/nar/gkv1507
10.1093/nar/gkv1507 · External reference
10.1038/nature25501
10.1038/nature25501 · External reference
10.1186/s13059-017-1349-1
10.1186/s13059-017-1349-1 · External reference
10.1093/bioinformatics/bti042
10.1093/bioinformatics/bti042 · External reference
Random survival forest to predict transplant-eligible newly diagnosed multiple myeloma outcome including FDG-PET radiomics: a combined analysis of two independent prospective European trials
10.1007/s00259-020-05049-6 · 2021 · External reference
Random Survival Forest in practice: a method for modelling complex metabolomics data in time to event analysis
10.1093/ije/dyw145 · 2016 · External reference
On the exact distribution of maximally selected rank statistics
10.1016/s0167-9473(02)00225-6 · 2003 · External reference
10.1016/j.immuni.2018.03.023
10.1016/j.immuni.2018.03.023 · External reference
10.1007/978-1-4939-7493-1_12
10.1007/978-1-4939-7493-1_12 · External reference
10.1038/nmeth.3337
10.1038/nmeth.3337 · External reference
10.1158/0008-5472.can-18-0689
10.1158/0008-5472.can-18-0689 · External reference
10.1016/j.it.2020.07.010
10.1016/j.it.2020.07.010 · External reference
10.1038/s41591-018-0157-9
10.1038/s41591-018-0157-9 · External reference
Siglec15 shapes a non-inflamed tumor microenvironment and predicts the molecular subtype in bladder cancer
10.7150/thno.53649 · 2021 · External reference
Varied phenotypes and management of immune checkpoint inhibitor-associated neuropathies
10.1212/wnl.0000000000008091 · 2019 · External reference
Disease-related cellular protein networks differentially affected under different EGFR mutations in lung adenocarcinoma
10.1038/s41598-020-67894-7 · 2020 · External reference
Identification of an immunologic signature of lung adenocarcinomas based on genome-wide immune expression profiles
2020 · External reference
10.1158/1078-0432.ccr-15-1434
10.1158/1078-0432.ccr-15-1434 · External reference
10.1038/nature13385
10.1038/nature13385 · External reference
10.7717/peerj.8128
10.7717/peerj.8128 · External reference
10.1172/jci91095
10.1172/jci91095 · External reference
The lncRNA SNHG5/miR-32 axis regulates gastric cancer cell proliferation and migration by targeting KLF4
10.1096/fj.201600994r · 2017 · External reference
Artificial analogues of circulating box C/D RNAs induce strong innate immune response and MicroRNA activation in human adenocarcinoma cells
10.1007/978-3-319-42044-8_24 · 2016 · External reference
10.1210/en.2015-1067
10.1210/en.2015-1067 · External reference
SNORD63 and SNORD96A as the non-invasive diagnostic biomarkers for clear cell renal cell carcinoma
10.1186/s12935-020-01744-4 · 2021 · External reference
10.1016/j.bcp.2014.05.011
10.1016/j.bcp.2014.05.011 · External reference
10.1007/s10147-017-1156-4
10.1007/s10147-017-1156-4 · External reference
Metabolic reprogramming and cancer progression
10.1126/science.aaw5473 · 2020 · External reference
10.1038/ng.3224
10.1038/ng.3224 · External reference
10.1038/ng.3225
10.1038/ng.3225 · External reference
10.1016/bs.ai.2015.12.002
10.1016/bs.ai.2015.12.002 · External reference
10.1080/2162402x.2017.1338237
10.1080/2162402x.2017.1338237 · External reference
10.1158/1078-0432.ccr-16-0392
10.1158/1078-0432.ccr-16-0392 · External reference
10.3390/cancers12010037
10.3390/cancers12010037 · External reference
10.1111/j.1349-7006.2001.tb01096.x
10.1111/j.1349-7006.2001.tb01096.x · External reference
10.4049/jimmunol.1003682
10.4049/jimmunol.1003682 · External reference
Association of survival and immune-related biomarkers with immunotherapy in patients with non-small cell lung cancer: a meta-analysis and individual patient-level analysis
10.1001/jamanetworkopen.2019.6879 · 2019 · External reference
The biomarkers of hyperprogressive disease in PD-1/PD-L1 blockage therapy
10.1186/s12943-020-01200-x · 2020 · External reference
Cancer biomarkers for targeted therapy
10.1186/s40364-019-0178-7 · 2019 · External reference
Lung adenocarcinoma-intrinsic GBE1 signaling inhibits anti-tumor immunity
10.1186/s12943-019-1027-x · 2019 · External reference
